This message was sent to ##Email##
|
|
|
CIDRAP
The World Health Organization recently raised the global COVID-19 risk to its highest level, as cases surged in three hot spots outside China, which are quickly spreading the virus to other countries, with many more — such as Nigeria and Mexico — reporting their first cases.
READ MORE
Infectious Disease Advisor
When treating infections caused by gram-negative pan-drug-resistant bacteria, colistin and/or tigecycline-based combination empiric therapy is recommended, according to results of a study published in the European Journal of Clinical Microbiology & Infectious Diseases.
READ MORE
Promoted by
|
|
|
 |
Children's Hospital Boston via Medical Xpress
Blood stem cells make all the different kinds of blood and immune cells in our body. Scientists have long been trying to make these cells in the lab and use them to make different blood cell types on demand.
READ MORE
Promoted by
|
|
|
 |
University of Montreal via Medical Xpress
HIV hides in reservoirs during antiretroviral therapy. These viral sanctuaries are the reason why ART is not a cure. And research teams have striven for years to determine how the HIV reservoirs are established and maintained during ART.
READ MORE
|
|
Infectious Disease Advisor
Daily doses of 10 to 15 mg/kg isoniazid demonstrated similar activity against tuberculosis strains with inhA mutations as 5 mg/kg doses against drug-sensitive strains, according to data published in the American Journal of Respiratory and Critical Care Medicine.
READ MORE
 |
|
The miniiSED® is the newest addition to the iSED® family of ESR analyzers from ALCOR Scientific. The miniiSED®is a single position, fully automated ESR analyzer that works directly from the primary EDTA tube and produces an ESR result in just 15 seconds. The miniiSED® is the ideal ESR analyzer for small laboratories, POL’s and emergency clinics.
|
|
University of California, San Diego via ScienceDaily
A comparison of normal and germ-free mice revealed that as much as 70% of a mouse's gut chemistry is determined by its gut microbiome. Even in distant organs, such as the uterus or the brain, approximately 20% of molecules were different in the mice with gut microbes.
READ MORE
Advertisement
American Medical Technologists
Enhance your credentials to work in the rapidly expanding field of molecular diagnostics
|
|
|
Infectious Disease Advisor
Infections with the 2019 novel coronavirus (2019-nCoV) was of clustering onset and more likely to affect older men with comorbid diseases, according to a study published in The Lancet. 2019-nCoV infection can result in severe and fatal respiratory diseases; mortality risk was consistent with the MuLBSTA scores used to predict mortality in viral pneumonia.
READ MORE
ContagionLive
Staphylococcus aureus is a major cause of both healthcare-acquired and community-acquired infections ranging from skin and soft tissue infections to more invasive infections like bacteremia. Staphylococcus aureus bacteremia results in a significant morbidity and mortality. Mortality rates of SAB in the preantibiotic era were 75-83%.
READ MORE
The Atlantic
You are reading this because of your ancestors’ immune system. The odds of your predecessors surviving the myriad microbes that have stalked humanity every step of its march toward becoming Earth’s dominant species were incalculably long.
READ MORE
DARK Daily
Medical laboratories are on the diagnostic front lines of efforts in the U.S. to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the disease COVID-19, which was first reported in Wuhan City, China. SARS-CoV-2 differs from severe acute respiratory syndrome coronavirus (SARS-CoV), which caused an outbreak of severe acute respiratory syndrome (SARS) in 2003.
READ MORE
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
Genetic Engineering & Biotechnology News
An international team of clinicians and researchers has had an unprecedented opportunity to examine what is likely to represent the early pathology of SARS-CoV-2 coronavirus in humans before symptoms develop. In an article, to be published in the Journal of Thoracic Oncology, a pre-proof of which is now available, Dr. Shu-Yuan Xiao, from the University of Chicago Medicine, and a group of clinicians from the Zhongnan Hospital of Wuhan University, describe their examination of surgically removed lung tissue from two patients who had undergone lung lobectomies for adenocarcinoma, but were retrospectively found to have had COVID-19 at the time of surgery.
READ MORE
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|